Ask AI
Bill114th CongressFiled Feb 4, 2016Health
S. 2503

Preventing Superbugs and Protecting Patients Act

Bill journey · stage 2 of 5

Under committee review

Filed
Comm.
Floor
Both
Law

What it doesSummary reported to senate with amendment(s) (Apr 5, 2016)

Preventing Superbugs and Protecting Patients Act

(Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to identify types of medical devices for which premarket notification must include proposed labeling, including validated instructions regarding cleaning, disinfection, and sterilization.

(Sec. 3) The FDA must issue final guidance regarding when a premarket notification is required for a modification to a medical device.

What just happenedApr 5, 2016

Placed on Senate Legislative Calendar under General Orders. Calendar No. 417.

Who’s behind it

Sen. Murray, Patty [D-WA](D-WA)Sponsor
Read on Congress.gov
1committees6actions2related bills7subjects
  1. Apr 5, 2016Calendars

    Placed on Senate Legislative Calendar under General Orders. Calendar No. 417.

  2. Apr 5, 2016Committee

    Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.

    Health, Education, Labor, and Pensions Committee
  3. Apr 5, 2016Committee14000

    Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.

    Health, Education, Labor, and Pensions Committee
  4. Feb 9, 2016Committee

    Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.

    Health, Education, Labor, and Pensions Committee
  5. Feb 4, 2016IntroReferral

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Health, Education, Labor, and Pensions Committee
  6. Feb 4, 2016IntroReferral10000

    Introduced in Senate

Reported to Senate with amendment(s)Apr 5, 20161

Preventing Superbugs and Protecting Patients Act

(Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to identify types of medical devices for which premarket notification must include proposed labeling, including validated instructions regarding cleaning, disinfection, and sterilization.

(Sec. 3) The FDA must issue final guidance regarding when a premarket notification is required for a modification to a medical device.
Introduced in SenateFeb 4, 2016

Preventing Superbugs and Protecting Patients Act

This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to identify types of medical devices for which premarket notification must include proposed labeling, including validated instructions regarding cleaning, disinfection, and sterilization.

The FDA must issue final guidance regarding when a premarket notification is required for a modification to a medical device.
Preventing Superbugs and Protecting Patients Act — Informed